120 participants
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-09-26
- Start Date:
- 2024-01-31
- Completion:
- 2029-12-31
Conditions
- Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
- Primary Mediastinal Large B-Cell Lymphoma
- Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
Interventions
- PROCEDURE
- BIOLOGICAL
- OTHER
No Results Yet